These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3901183)

  • 21. The clinical course of lupus nephritis: relationship to the renal histologic findings.
    Pollak VE; Pirani CL; Dujovne I; Dillard MG
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1167-81. PubMed ID: 4139685
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prognosis and treatment of patients with systemic lupus erythematosus in different age groups].
    Ivanova MM
    Ter Arkh; 1985; 57(6):125-8. PubMed ID: 4071400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lupus nephritis.
    Barsoum RS; Shaheen MH; Soliman MM; El-Sheemy N; Milad M; Hassaballa A
    J Egypt Med Assoc; 1977; 60(5-6):363-83. PubMed ID: 755829
    [No Abstract]   [Full Text] [Related]  

  • 24. [A clinical study on male patients with systemic lupus erythema].
    You YH; Wu CL
    Hunan Yi Ke Da Xue Xue Bao; 2000 Oct; 25(5):499-501. PubMed ID: 12212133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changing pattern of clinical features and prognosis in systemic lupus erythematosus.
    Hashimoto H; Shiokawa Y
    Scand J Rheumatol; 1978; 7(4):219-24. PubMed ID: 734380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Significance of the tubulointerstitial and fibroplastic components of nephritis for the prognosis of kidney lesions in systemic lupus erythematosus].
    Demin AA; Semenova LA; Sentiakova TN; Poliachenko EA; Smirnov VV
    Urol Nefrol (Mosk); 1986; (1):28-31. PubMed ID: 3952899
    [No Abstract]   [Full Text] [Related]  

  • 27. [Significance of urine glycosaminoglycan determination for the characterization of pathological processes in systemic lupus erythematosus].
    Astakhova TA; Folomeeva OM
    Ter Arkh; 1981; 53(7):36-43. PubMed ID: 7292315
    [No Abstract]   [Full Text] [Related]  

  • 28. [Course and prognosis of systemic lupus erythematosus. Evaluation based on the analysis of 41 own observations].
    Vachtenheim J
    Cas Lek Cesk; 1967 Aug; 106(34):924-9. PubMed ID: 5584207
    [No Abstract]   [Full Text] [Related]  

  • 29. [Variations of the course of lupous nephritis].
    Tareeva IE
    Sov Med; 1971 Nov; 34(11):70-6. PubMed ID: 5160641
    [No Abstract]   [Full Text] [Related]  

  • 30. Mortality in lupus nephritis.
    Karsh J; Klippel JH; Balow JE; Decker JL
    Arthritis Rheum; 1979 Jul; 22(7):764-9. PubMed ID: 454503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The significance of electron dense deposits in mild lupus nephritis.
    Domoto DT; Kashgarian M; Hayslett JP; Adler M; Siegel NJ
    Yale J Biol Med; 1980; 53(4):317-24. PubMed ID: 7445538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus.
    Ward MM; Pyun E; Studenski S
    Arch Intern Med; 1996 Jun; 156(12):1337-44. PubMed ID: 8651844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet and plasma serotonin in glomerulonephritis. III: The nephritis of systemic lupus erythematosus.
    Parbtani A; Frampton G; Yewdall V; Kasai N; Cameron JS
    Clin Nephrol; 1980 Oct; 14(4):164-72. PubMed ID: 7428190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The analysis of lupus nephropathy in the light of own material (author's transl)].
    Hanicki Z; Jaszcz W; Zabińska K
    Przegl Lek; 1981; 38(3):331-4. PubMed ID: 7244291
    [No Abstract]   [Full Text] [Related]  

  • 35. [Visceral lupus erythematosus].
    Meyer zum Büschenfelde ; Knolle J
    Med Klin; 1969 Jul; 64(29):1297-302. PubMed ID: 4184548
    [No Abstract]   [Full Text] [Related]  

  • 36. [Ultra-high (shock) doses of methylprednisolone in lupus nephritis].
    Solov'ev SK; Ivanova MM
    Ter Arkh; 1980; 52(4):121-3. PubMed ID: 7404327
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical variants, clinical course and prognosis in lupus nephritis in children].
    Kartashova VI
    Pediatriia; 1983 Nov; (11):42-6. PubMed ID: 6669433
    [No Abstract]   [Full Text] [Related]  

  • 38. Mortality in systemic lupus erythematosus: the bimodal pattern revisited.
    Rubin LA; Urowitz MB; Gladman DD
    Q J Med; 1985 Apr; 55(216):87-98. PubMed ID: 4011845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies.
    Pradhan VD; Badakere SS; Bichile LS; Almeida AF
    J Assoc Physicians India; 2004 Jul; 52():533-7. PubMed ID: 15645975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crescentic lupus glomerulonephritis.
    Yeung CK; Wong KL; Wong WS; Ng MT; Chan KW; Ng WL
    Clin Nephrol; 1984 May; 21(5):251-8. PubMed ID: 6733993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.